Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2020-04-10 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
109年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 景岳, providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not present a full report but rather a regulatory disclosure of specific financial information. There is no indication of an annual or quarterly report, audit report, or earnings release. Given the nature and length, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-04-10 Chinese
109年3月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 景岳, with data for March 2020 (民國109年03月). It includes percentage changes compared to the previous year and explanatory notes about accounting standards and reporting practices. The document is very short (766 characters) and contains no detailed financial statements or management discussion. It appears to be a regulatory disclosure of financial summary data rather than a full financial report or earnings release. There is no indication that this is an announcement of a report publication or a certification. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-04-10 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (景岳生物科技股份有限公司) regarding its commitments and subsequent execution related to its application for stock listing transfer from over-the-counter to the main board. It references compliance with a Taiwan Stock Exchange regulation and reports on the status of financial report audits for the first quarter of 2020. The document is short (768 characters) and primarily provides an update on regulatory compliance and commitments rather than containing financial statements or detailed financial data. It does not present a full report but rather a regulatory disclosure or announcement. Therefore, it fits best under Regulatory Filings (RNS).
2020-04-01 Chinese
108年度財務比率
Financial Supplement Data Classification · 85% confidence The document contains a financial data table summarizing key financial ratios and metrics for three fiscal years (106年度, 107年度, 108年度), which corresponds to a three-year financial data analysis. The content is structured as a financial summary with ratios related to financial structure, debt repayment ability, operating ability, profitability, and cash flow. The document length is 999 characters, which is relatively short and appears to be a summary rather than a full detailed report. There is no indication that this is an announcement or publication notice of a report, nor is it a certification or a regulatory filing. The document is not a full annual report (10-K) or interim report (IR) because it lacks comprehensive financial statements and detailed analysis. It is also not a simple factsheet (FS) because it covers multiple years and detailed financial ratios. Given the nature of the content as a financial data summary over multiple years, it best fits the category of Financial Supplement Data (XLSX), which includes supplementary financial data summaries, even though the format here is text, the content aligns with supplementary financial data presentation. Therefore, the most appropriate classification is Financial Supplement Data (XLSX).
2020-03-31 Chinese
108年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts, investment methods, and related financial figures concerning investments in mainland China by a Taiwanese listed company. It includes specific financial data such as capital amounts, investment income, and investment losses for the period ending in the fourth quarter of the 108th year (Taiwan calendar, equivalent to 2019). The document also references regulatory limits and approvals by the Economic Ministry Investment Commission, indicating compliance and reporting requirements. The content is focused on investment details rather than a full financial report or earnings release. It is a regulatory disclosure related to investment activities, but it is not a full annual or interim report, nor is it an announcement or certification. Given the nature and length (1428 characters), it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-03-30 Chinese
108年第4季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the fiscal year 108 (2019) Q4, with detailed financial data including operating, investing, and financing activities. The presence of actual financial figures and the nature of the content indicate this is a financial report rather than an announcement or summary. The document length is 2700 characters, which is relatively short but contains substantive financial data. Given it is a quarterly period report with detailed financial statements, it fits the definition of an Interim / Quarterly Report (IR). FY 2019
2020-03-30 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.